PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.99%
Negative revenue growth while VMC stands at 26.81%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-89.69%
Negative gross profit growth while VMC is at 42.88%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.53%
Negative EBIT growth while VMC is at 153.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.53%
Negative operating income growth while VMC is at 153.00%. Joel Greenblatt would press for urgent turnaround measures.
-4.08%
Negative net income growth while VMC stands at 137.50%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.08%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.08%
Reduced diluted shares while VMC is at 1.23%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
177.57%
10Y revenue/share CAGR 1.25-1.5x VMC's 149.34%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
143.54%
5Y revenue/share CAGR 1.25-1.5x VMC's 101.21%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
72.79%
3Y revenue/share CAGR 1.25-1.5x VMC's 50.94%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
200.00%
5Y net income/share CAGR above 1.5x VMC's 100.00%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
90.91%
3Y net income/share CAGR above 1.5x VMC's 10.71%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.